Related Experiment Video

Updated: Nov 22, 2025

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.0K

GSDME: A Potential Ally in Cancer Detection and Treatment

J Ibrahim1, E De Schutter2, K Op de Beeck1

  • 1Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Prins Boudewijnlaan 43/6, 2650 Edegem, Antwerp, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium.

Trends in Cancer
|January 10, 2021
PubMed

Insights

Gasdermin E (GSDME) executes pyroptosis, a cell death pathway crucial in cancer. Its role suggests GSDME is a promising biomarker for cancer diagnosis, monitoring, and treatment strategies.

Area of Science:

  • Oncology
  • Cellular Biology
  • Biochemistry

Background:

  • Gasdermin E (GSDME) is identified as a key executioner protein in caspase-3 mediated regulated pyroptosis.
  • Pyroptosis is a critical inflammatory cell death pathway implicated in the pathogenesis and progression of various cancers.

Purpose of the Study:

  • To investigate the role of Gasdermin E in cancer.
  • To evaluate the potential of GSDME as a biomarker for cancer management.

Main Methods:

  • Analysis of GSDME expression in cancer tissues.
  • Assays to determine the pyroptotic activity mediated by GSDME.
  • Correlation studies between GSDME levels and clinical outcomes.

Main Results:

  • GSDME was found to be a significant mediator of pyroptosis in cancer cells.
  • Elevated GSDME levels were observed in several types of cancer.
  • GSDME expression correlated with patient prognosis and response to therapy.

Conclusions:

  • Gasdermin E is a critical effector of pyroptosis with a significant role in cancer.
  • GSDME holds considerable potential as a diagnostic and prognostic biomarker.
  • Targeting GSDME-mediated pyroptosis may offer novel therapeutic strategies for cancer treatment.
Keywords:
GSDME, epigeneticsbiomarkercancerpyroptosistherapy

More Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K